Showing results (461-470 of 485) with videos related to

Sort By:
Pageof 49
Human Gene Therapy. Clinical Development|March 14, 2019
Safety and Toxicology of Ocular Gene Therapy with Recombinant AAV Vector rAAV.hCNGA3 in Nonhuman PrimatesPeters Tobias, Seitz Immanuel Philipp, Michalakis Stylianos, et al.
Acta Ophthalmologica|March 1, 2019
Changes in microchip position after implantation of a subretinal vision prosthesis in humansLaura Kuehlewein, Nicole Troelenberg, Krunoslav Stingl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2017
AAV8 Can Induce Innate and Adaptive Immune Response in the Primate EyeFelix F Reichel, Daniyar L Dauletbekov, Reinhild Klein, et al.
The British Journal of Ophthalmology|May 24, 2022
Development of retinal atrophy after subretinal gene therapy with voretigene neparvovecFelix Friedrich Reichel, Immanuel Seitz, Fabian Wozar, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 25, 2010
Restoration of useful vision up to letter recognition capabilities using subretinal microphotodiodesHeval Benav, Karl U Bartz-Schmidt, Dorothea Besch, et al.
Investigative Ophthalmology & Visual Science|May 8, 2012
Positioning of electronic subretinal implants in blind retinitis pigmentosa patients through multimodal assessment of retinal structuresAkos Kusnyerik, Udo Greppmaier, Robert Wilke, et al.
Acta Ophthalmologica|September 30, 2022
DMEK outcome after one year - Results from a large multicenter study in GermanyKristina Spaniol, Martin Hellmich, Klara Borgardts, et al.
The British Journal of Ophthalmology|January 21, 2021
Spatial and temporal resolution of the photoreceptors rescue dynamics after treatment with voretigene neparvovecKrunoslav Stingl, Melanie Kempf, Karl U Bartz-Schmidt, et al.
Human Gene Therapy. Clinical Development|September 7, 2018
Development of Methodology and Study Protocol: Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients with CNGA3-Linked Achromatopsia Investigated in an Exploratory Dose-Escalation TrialNadine A Kahle, Tobias Peters, Ditta Zobor, et al.
Proceedings. Biological Sciences|February 22, 2013
Artificial vision with wirelessly powered subretinal electronic implant alpha-IMSKatarina Stingl, Karl Ulrich Bartz-Schmidt, Dorothea Besch, et al.
Pageof 49